FCP
ELV icon

Fidelis Capital Partners’s Elevance Health ELV Stock Holding History

Fidelis Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$629K Buy
1,627
+89
+6% +$33K 0.04% 299
2026
Q1 		$450K Sell
1,538
-40
-3% -$13.1K 0.03% 338
2025
Q4 		$553K Buy
1,578
+15
+1% +$5.07K 0.04% 292
2025
Q3 		$505K Buy
1,563
+22
+1% +$6.84K 0.04% 303
2025
Q2 		$426K Sell
1,541
-150
-9% -$60.3K 0.04% 297
2025
Q1 		$713K Buy
1,691
+65
+4% +$26.1K 0.08% 197
2024
Q4 		$659K Sell
1,626
-2,425
-60% -$1.01M 0.07% 216
2024
Q3 		$1.68M Buy
4,051
+499
+14% +$267K 0.2% 88
2024
Q2 		$1.85M Buy
3,552
+1,168
+49% +$617K 0.26% 72
2024
Q1 		$1.24M Buy
2,384
+840
+54% +$418K 0.19% 96
2023
Q4 		$728K Buy
1,544
+232
+18% +$107K 0.16% 127
2023
Q3 		$573K Sell
1,312
-66
-5% -$29.9K 0.2% 117
2023
Q2 		$612K Buy
1,378
+111
+9% +$51.2K 0.22% 109
2023
Q1 		$588K Buy
+1,267
New +$603K 0.25% 99

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelis Capital Partners's ELV Position: Q2 2026 in Review

Fidelis Capital Partners increased its Elevance Health (ELV) stake by 5.8% in Q2 2026, buying an estimated $33K and bringing the position to 1,627 shares worth $629K. The position accounts for 0.04% of the portfolio, ranked #299.

Fidelis Capital Partners first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.85M in Q2 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fidelis Capital Partners held 1,627 shares of Elevance Health worth $629K as of Q2 2026.
  • Fidelis Capital Partners bought 89 Elevance Health shares in Q2 2026, an estimated $33K.
  • Elevance Health made up 0.04% of Fidelis Capital Partners's portfolio in Q2 2026, its #299 holding.
  • Fidelis Capital Partners first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
  • Fidelis Capital Partners's Elevance Health position peaked at $1.85M in Q2 2024.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.